Bone marrow transplantation (BMT) and peripheral blood stem cell transplantation (PBSCT) are procedures that restore stem cells that have been destroyed by high doses of chemotherapy and/or radiation therapy. There are three types of transplants:
- In autologous transplants, patients receive their own stem cells.
- In syngeneic transplants, patients receive stem cells from their identical twin.
- In allogeneic transplants, patients receive stem cells from someone other than the patient or an identical twin. The patient’s brother, sister, or parent may serve as the donor, or a person not related to the patient (an unrelated donor) may be used.
Patients at UMGCC receive the most advanced treatments available and are seen and evaluated by a skilled transplant team, including medical oncologists/hematologists, pathologists, nurses, nutritionists, social workers, and genetic counselors, among others.
Our team of specialists offers a comprehensive array of services designed to provide patients with the most effective care possible. Services include:
- Consultations on complicated cases
- Self-contained state-of-the-art unit dedicated to allogeneic and autologous stem cell transplantation
- Hepa-filtered inpatient transplantation unit designed to provide optimum protection from infection in an environment that is comfortable for patients and family members
- Allogeneic/syngeneic/autologous stem cell transplantation services
- On-site stem cell collection facility
- Developmental translational programs in adoptive immunotherapy, stem cell manipulation, and graft engineering
- New therapies
- Sophisticated HLA (tissue typing) laboratory
Patients have complete access to the full range of medical support services at the University of Maryland Medical Center.
This page was last updated: April 8, 2015